Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy - Kavanaugh,A.; Clair,E.W.; McCune,W.J.; Braakman,T.; Lipsky,P. (J Rheumatol, 2000)